Aller au contenu
Santé cardiovasculaireMéta-analyse observationnelle3 min read

Higher dietary magnesium linked to slightly lower hypertension risk in cohort studies

Collectif éditorial MoveVitals · Study published · Reading updated

Original paper:Dose-response relationship between dietary magnesium intake, serum magnesium concentration and risk of hypertension: a systematic review and meta-analysis of prospective cohort studies. · Nutrition journal · 2017 · Article original ↗

À retenir

Pooling 9 articles covering 10 cohort studies (180,566 participants, 20,119 hypertension cases), the highest dietary magnesium intake was linked to 8% lower hypertension risk than the lowest (RR 0.92, 95% CI 0.86-0.98). Blood magnesium showed only a marginal link (RR 0.91, 0.80-1.02), and observational cohorts cannot prove magnesium itself lowers blood pressure.

Study design

Méta-analyse observationnelle

Reading basis

Published abstract

Reading focus

Design & applicability

Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.

Question de recherche

Earlier cohort studies disagreed on whether eating more magnesium, or having higher blood magnesium, relates to lower hypertension risk. The authors pooled prospective cohort studies to test the link and to estimate how risk changes with each extra amount of magnesium.

Population et méthode

Systematic review and dose-response meta-analysis of prospective cohort studies. PubMed, EMBASE and the Cochrane Library were searched from October 1951 through June 2016 for studies reporting effect estimates with 95% confidence intervals for hypertension across more than two categories of dietary magnesium intake and/or serum magnesium. Random-effects models combined the estimates. Nine articles (six on dietary intake, two on serum magnesium and one on both) were eligible, from ten cohort studies.

Résultats

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    Highest versus lowest dietary magnesium intake was associated with lower hypertension risk (RR 0.92, 95% CI 0.86-0.98).
  2. 2
    Each 100 mg/day increase in magnesium intake was associated with a 5% lower risk (RR 0.95, 95% CI 0.90-1.00); the interval reaches 1.00, so this is borderline.
  3. 3
    For serum magnesium, the association was marginally significant and not clear-cut (RR 0.91, 95% CI 0.80-1.02).
  4. 4
    The meta-analysis pooled 20,119 hypertension cases among 180,566 participants.

Limites et incertitude

  1. 1
    All data are from observational cohorts, so people who eat more magnesium (from vegetables, nuts, whole grains) may differ in other healthy habits that explain part of the link.
  2. 2
    Very few studies assessed serum magnesium (three of the nine articles), so that result is weak and imprecise.
  3. 3
    The abstract does not report heterogeneity, how intake was measured or the countries included, which limits judgement of reliability.
  4. 4
    The dose-response result is borderline, with a confidence interval touching 1.00.

Mise en perspective

Getting magnesium from a varied diet with vegetables, legumes, nuts and whole grains fits this finding, and its effect on blood pressure is small. This evidence does not support taking magnesium supplements to prevent or treat hypertension; discuss supplements and blood pressure management with your clinician.

Vos données

A food log can estimate your usual magnesium intake from foods, though app databases are approximate. If you measure blood pressure at home, use the same validated cuff, rest first, and look at the average of readings over weeks, because a small diet effect is hard to see in single measurements.

Comprendre ce type de preuve

Pooling observational studies does not remove their confounding. Check overlapping cohorts and whether relative effects are being confused with absolute benefits.

Résumé structuré des auteurs English

Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.

Background

The findings of prospective cohort studies are inconsistent regarding the association between dietary magnesium intake and serum magnesium concentration and the risk of hypertension. We aimed to review the evidence from prospective cohort studies and perform a dose-response meta-analysis to investigate the relationship between dietary magnesium intake and serum magnesium concentrations and the risk of hypertension.

Methods

We searched systematically PubMed, EMBASE and the Cochrane Library databases from October 1951 through June 2016. Prospective cohort studies reporting effect estimates with 95% confidence intervals (CIs) for hypertension in more than two categories of dietary magnesium intake and/or serum magnesium concentrations were included. Random-effects models were used to combine the estimated effects.

Results

Nine articles (six on dietary magnesium intake, two on serum magnesium concentration and one on both) of ten cohort studies, including 20,119 cases of hypertension and 180,566 participates, were eligible for inclusion in the meta-analysis. We found an inverse association between dietary magnesium intake and the risk of hypertension [relative risk (RR) = 0.92; 95% CI: 0.86, 0.98] comparing the highest intake group with the lowest. A 100 mg/day increment in magnesium intake was associated with a 5% reduction in the risk of hypertension (RR = 0.95; 95% CI: 0.90, 1.00). The association of serum magnesium concentration with the risk of hypertension was marginally significant (RR = 0.91; 95% CI: 0.80, 1.02).

Conclusions

Current evidence supports the inverse dose-response relationship between dietary magnesium intake and the risk of hypertension. However, the evidence about the relationship between serum magnesium concentration and hypertension is limited.

Sources et attribution

Dose-response relationship between dietary magnesium intake, serum magnesium concentration and risk of hypertension: a systematic review and meta-analysis of prospective cohort studies.

Han H, Fang X, Wei X, Liu Y, Jin Z, Chen Q, Fan Z, Aaseth J, Hiyoshi A, He J, Cao Y.

Nutrition journal · 2017-05-05

DOI: 10.1186/s12937-017-0247-4 ↗PubMed · 28476161 ↗Europe PMC · Licence indiquée: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée

Sources vérifiées 2026-11-01

Guides pratiques

À lire ensemble

·Méta-analyse observationnelle

Disrupted daily rest-activity rhythm is linked to higher mortality in 109,365 people

Across seven observational studies with 109,365 participants, a weaker day-night activity contrast (lower relative amplitude) was associated with higher cardiovascular mortality (hazard ratio [HR] 1.50, 95% CI 1.13 to 1.98) and all-cause mortality (HR 1.46, 95% CI 1.27 to 1.68). The evidence base is small and observational, so it cannot show that improving the rhythm lowers risk, and illness may itself disturb the rhythm.

Journal of the American Heart Association

Explications approfondiesLire l’étude →
·Méta-analyse d’essais

Five exercise types lowered resting blood pressure, isometric training the most

Pooling 270 randomised trials with 15,827 participants, aerobic, resistance, combined, interval and isometric training all lowered resting blood pressure compared with non-intervention controls (P<0.001 for each), with the largest fall for isometric training: 8.24 mm Hg systolic and 4.00 mm Hg diastolic. The ranking between modes is partly indirect and the trials differ, so it is not a personal prescription.

British Journal of Sports Medicine

Explications approfondiesLire l’étude →
·Essai randomisé

A salt substitute lowered stroke, major cardiovascular events and death in rural China

In 20,995 people in 600 rural Chinese villages who had a history of stroke or were 60 or older with high blood pressure, a salt substitute (75% sodium chloride, 25% potassium chloride) lowered the stroke rate versus regular salt over a mean 4.74 years: 29.14 versus 33.65 events per 1000 person-years (rate ratio 0.86, 95% CI 0.77 to 0.96; P = 0.006). Death was also lower (rate ratio 0.88) and serious hyperkalemia events were not significantly higher, but the trial was open-label and set in rural China.

The New England Journal of Medicine

Explications approfondiesLire l’étude →
·Validation : étude/revue

Apple Watch irregular-pulse alerts were rare; 34% of those tested had atrial fibrillation

Among 419,297 Apple Watch users with no known atrial fibrillation (AF), 0.52% received an irregular-pulse alert, and 34% of the 450 who returned a usable ECG patch had AF (97.5% CI 29 to 39). Alerts that coincided with patch recording matched AF with a positive predictive value of 0.84 (95% CI 0.76 to 0.92), but only 20.8% of alerted people returned a patch and nobody without an alert was monitored, so a quiet watch does not rule AF out.

The New England Journal of Medicine

Explications approfondiesLire l’étude →
Santé cardiovasculaire →